Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Clovis sells $20mm of its debt to multiple investors

Executive Summary

Clovis Oncology Inc. (developing cancer drugs and companion diagnostics) sold $20mm of its debt and other securities to 18 undisclosed investors. The company's last fundraising activity was back in May 2009 when it got $146mm in seed money from backers including Domain, NEA, Versant, and Abingworth.
Deal Industry
  • Biotechnology
  • In Vitro Diagnostics
  • Pharmaceuticals
    • Specialty Pharmaceuticals
Deal Status
  • Final
Deal Type
  • Financing
    • Convertible Debt
    • Private Placement

Related Companies